Live tape
Top 8, mentions 7d29,843NVDA14,475 mentions▲ +0.04ANT4,133 mentions▲ +0.06GOOGL2,915 mentions▲ +0.04SPY2,239 mentions▲ +0.05QQQ1,797 mentions▲ +0.04SPCX1,742 mentions▲ +0.08AMD1,362 mentions▲ +0.06AAPL1,180 mentions▲ +0.04

Equity · Healthcare

VRTX

NASDAQ

Vertex Pharmaceuticals (VRTX)

514.99 USD −1.07% vs prior close Nov 20, 2026
Vertex Pharmaceuticals Incorporated price graph
64 sessions
575 475 24 Aug 20 Nov

The line runs 547.71 USD on 24 August through 514.99 USD on 20 November, on a scale from 475 to 575. Days the market did not trade hold the previous close, flat.

Market cap
130.6B USD
P/E (TTM)
33.2
Revenue, year to Dec 2025
12.0B USD
EPS, diluted, year to Dec 2025
15.32 USD
52-week range
421.03 USD – 569.99 USD
Avg volume
85.5K
Mentions, 30 days
14
Net sentiment
+0.09

as of Nov 20, 2026

Have Vertex Pharmaceuticals (VRTX) insiders bought or sold shares recently?

In the 90 days to 22 Nov 2026, Vertex Pharmaceuticals insiders reported 4 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 13 Feb 2026, show no open-market purchase.

Form 4, 90 days to 22 Nov 2026, newest reported trade 16 Nov 2026

0buys
4sells
$15.38Mnet sold
4other filings
Have Vertex Pharmaceuticals (VRTX) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
16 Nov 2026Bhatia Sangeeta N.DirectorSell271148K USD
16 Nov 2026Thornberry NancyDirectorSell1,000548K USD
12 Nov 2026WAGNER CHARLES F JREVP, CO & FOSell15,2868.4M USD
06 Nov 2026Kewalramani ReshmaCEO & PresidentSell11,8666.3M USD
Sold4 open-market sales28,423$15.38M
4 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have Vertex Pharmaceuticals (VRTX) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
20 Oct 2026Brennan Daniel J.DirectorAward795400K USD
08 Sep 2026van Grunsven JasperEVP, CP and NPPOAward8,682
28 Aug 2026Ambrose KristenSVP & Chief Accounting OfficerAward5,000
27 Aug 2026SACHS BRUCE IDirectorGift6,000

Which funds hold Vertex Pharmaceuticals (VRTX)?

12 of the 45 institutional funds we track reported a Vertex Pharmaceuticals position for the quarter ended 30 Sep 2026 — a combined 1.9B USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Vertex Pharmaceuticals (VRTX)?
FundPositionSharesValueShares q/q
Citadel AdvisorsAdded1,032,674539.9M USD+102.3%
Millennium ManagementHeld (±25%)567,655296.8M USD+21.2%
AQR Capital ManagementHeld (±25%)499,767261.3M USD−18.9%
Marshall WaceHeld (±25%)412,702215.8M USD−24.1%
Renaissance TechnologiesHeld (±25%)396,768207.4M USD+24.0%
Balyasny Asset ManagementAdded230,771120.6M USD+59.1%
Two Sigma InvestmentsTrimmed203,123106.2M USD−28.7%
Man GroupHeld (±25%)132,60769.3M USD−4.8%
Bridgewater AssociatesAdded34,91518.3M USD+221.4%
Fisher Asset ManagementHeld (±25%)28,67615.0M USD+17.2%

Showing the 10 largest of 12 reported positions. The figures above count all of them.

Have members of Congress traded Vertex Pharmaceuticals (VRTX)?

The most recent congressional trade disclosed in Vertex Pharmaceuticals is a purchase by David J. Taylor (house, OH), dated 07 Aug 2025.

STOCK Act disclosures

Have members of Congress traded Vertex Pharmaceuticals (VRTX)?
TradedMemberTypeAmountFiled after
07 Aug 2025David J. Taylorhouse · Republican–OHPurchase1K USD–15K USD26 days
11 Jun 2025Lisa C. McClainhouse · Republican–MISale1K USD–15K USD63 days
10 Jun 2025Lisa C. McClainhouse · Republican–MISale1K USD–15K USD64 days
12 May 2025Jefferson Shrevehouse · Republican–INSale15K USD–50K USD41 days
20 Mar 2025Byron Donaldshouse · Republican–FLSale1K USD–15K USD25 days
24 Feb 2025Jefferson Shrevehouse · Republican–INPurchase15K USD–50K USD13 days
11 Dec 2024Lisa C. McClainhouse · Republican–MIPurchase1K USD–15K USD245 days
24 Oct 2023Greg Stantonhouse · Democrat–AZSale1K USD–15K USD16 days

What has been filed or recorded for Vertex Pharmaceuticals (VRTX)?

The filings we hold for Vertex Pharmaceuticals, newest first: 6 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 29 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Vertex Pharmaceuticals (VRTX)?
And
29 Oct 2026Fails to deliverShares failed to deliver1 shares530 USD notional · <0.001% of shares out
28 Oct 2026Fails to deliverShares failed to deliver5 shares3K USD notional · <0.001% of shares out
27 Oct 2026Fails to deliverShares failed to deliver15 shares8K USD notional · <0.001% of shares out
14 Oct 2026Fails to deliverShares failed to deliver424 shares206K USD notional · <0.001% of shares out
13 Oct 2026Fails to deliverShares failed to deliver919 shares466K USD notional · <0.001% of shares out
09 Oct 2026Fails to deliverShares failed to deliver46 shares23K USD notional · <0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS 2.56 USD
30 Sep 2026FinancialsTotal assets32.7B USDat period end
30 Sep 2026FinancialsTotal equity20.9B USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS 4.31 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS 4.02 USD
31 Dec 2025Annual reportFY 2025 reportedEPS 15.32 USD
31 Dec 2025FinancialsRevenue12.0B USDfiscal year
31 Dec 2025FinancialsNet income4.0B USDfiscal year
31 Dec 2025FinancialsDiluted EPS15.32 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS 4.20 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS 3.99 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS 2.49 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −2.08 USD

What is Reddit saying about Vertex Pharmaceuticals (VRTX)?

Reddit mentioned VRTX 14 times in the 30 days to 21 November 2026, across 3 of the communities we track. All of them were scored for sentiment: 64% read bullish, 0% bearish and 36% neither. Reddit data updated 21 November 2026.

30-day window, Method

14mentions, 30 days
64%bullish
0%bearish
3communities
+12pointsagainst the market

How do Reddit mentions of Vertex Pharmaceuticals (VRTX) compare with its price?

Share ↗
14 mentions

Which subreddits are talking about Vertex Pharmaceuticals (VRTX)?

30 days

Which subreddits are talking about Vertex Pharmaceuticals (VRTX)?
CommunityShareMentionsNet sentiment
r/wallstreetbets57%8+0.07
r/stocks29%4+0.09
r/investing14%2+0.15

Which names move with Vertex Pharmaceuticals (VRTX) on Reddit?

6 names, 30 days

BMWYY moved most closely with Vertex Pharmaceuticals (VRTX): when the crowd talked about one, it talked about the other (+0.67 over 31 days). Co-discussion, not price.

How closely VRTX's daily Reddit mentions moved with each name, 30 days
BMWYY
Palm OIL
SQ
VRTX
+0.67+0.65+0.64+0.62+0.61+0.61
View the matrix as a tableHide the table
Names that move with VRTX on Reddit, 30 days
PairMatchDays measured
VRTX and BMWYY+0.6731 days
VRTX and FTW+0.6531 days
VRTX and Palm OIL+0.6431 days
VRTX and FHB+0.6231 days
VRTX and Barc.l+0.6131 days
VRTX and SQ+0.6131 days

What do people ask about Vertex Pharmaceuticals (VRTX)?

From live data
What did Vertex Pharmaceuticals shares close at?514.99

Vertex Pharmaceuticals closed at 514.99 USD on 20 Nov 2026, down 1.07% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Vertex Pharmaceuticals’ market cap?130.6B

Vertex Pharmaceuticals is worth 130.6B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.

What is Vertex Pharmaceuticals’ P/E ratio?33.2

Vertex Pharmaceuticals has a price-to-earnings ratio of 33.2, as of 20 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.

What is Vertex Pharmaceuticals’ revenue?12.0B

Vertex Pharmaceuticals reported revenue of 12.0B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Vertex Pharmaceuticals insiders bought or sold shares recently?4 sales

In the 90 days to 22 Nov 2026, Vertex Pharmaceuticals insiders reported 4 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 13 Feb 2026, show no open-market purchase. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own Vertex Pharmaceuticals?12 of 45

12 of the 45 funds we track reported a Vertex Pharmaceuticals position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Millennium Management and AQR Capital Management. See Funds

Have members of Congress traded Vertex Pharmaceuticals?15 trades

Yes. 15 trades in Vertex Pharmaceuticals appear in the congressional disclosures we hold; the latest is a purchase by David J. Taylor (House, OH) dated 7 Aug 2025, filed 2 Sep 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

When did Vertex Pharmaceuticals last report earnings?2.56

Vertex Pharmaceuticals last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 2.56 USD; no next date is announced in SEC filings yet. See Filings

What is Reddit saying about Vertex Pharmaceuticals?2 mentions

Vertex Pharmaceuticals was mentioned 2 times in the last 7 days across the finance subreddits we track, and 14 times over the trailing 30 days. Of the 14 mentions scored for sentiment, 64% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. Wikimedia CommonsPortraits via Wikimedia Commons. Lisa C. McClain: Office of Congresswoman Lisa McClain, Public domain; Byron Donalds: United States Congress, Public domain; Jefferson Shreve: House Creative Services, Public domain; David J. Taylor: Ike Hayman, House Creative Services, Public domain; Greg Stanton: United States Congress, Public domain.
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SECSEC fails-to-deliver (CNS) data
  9. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  10. SEC EDGARreported earnings figures and scheduled report dates
  11. SEC EDGARValuation computed from SEC EDGAR filings
  12. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words